Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
2
×
drug development
ipo
laura shawver
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
startups
2
×
vc
2
×
venture capital
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
armo biosciences
asklepios biopharmaceutical
autoimmune
avalon ventures
bioeurope
biogen
biomarin pharmaceutical
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cara therapeutics
coi pharmaceuticals
correlation ventures
crohn's disease
cytokines
deals
deerfield management
detroit blog main
What
ipo
2
×
activity
advance
approvals
bio
biogen
biology
clamped
company
covid
cytokine
delays
developing
drugs
economic
enhanced
fast
fda
files
including
initial
isn’t
laying
lot
medicines
money
new
offering
oric’s
plans
public
raise
roundup
san
showing
spread
suite
synthetic
synthorx
testing
Language
unset
Current search:
cancer
×
startups
×
ipo
×
vc
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs